Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
CLI Leadership & Staff

Ingrid Skop, M.D., FACOG

Vice President and Director of Medical Affairs

Ingrid Skop, M.D., FACOG, is Vice President and Director of Medical Affairs for Charlotte Lozier Institute, leveraging more than 30 years’ experience as a practicing obstetrician-gynecologist to support research and policies that respect the dignity of every human life.

Dr. Skop received her Bachelor of Science in physiology from Oklahoma State University and her medical doctorate from Washington University School of Medicine. She completed her residency in obstetrics and gynecology at the University of Texas Health Science Center at San Antonio. Dr. Skop is a Fellow of the American College of Obstetricians and Gynecologists, where she uses science and statistics to counter pro-abortion agendas, and is a lifetime member of the American Association of Pro-Life Obstetricians and Gynecologists.

Prior to joining Charlotte Lozier Institute, Dr. Skop served for over 25 years in private practice in San Antonio, where she delivered more than 5,000 babies and personally cared for many women who had been harmed, physically and emotionally, from complications due to abortion. She has served as board member and medical director for pregnancy resource centers in San Antonio, Austin, and Houston. 

Dr. Skop’s research on maternal mortality, abortion, and women’s health has been published in multiple peer-reviewed journals. Additionally, she has provided expert testimony at both the state and federal levels on legislation related to abortion, including standing firm against prominent pro-abortion politicians who choose not to follow the science regarding fetal heartbeat and development.

Dr. Skop is married to a physician and is the proud mother of two sons and a daughter.

To learn more about Dr. Ingrid Skop’s journey as a pro-life obstetrician-gynecologist, please watch this video:

Research Authored

Chemical Abortion

Chemical Abortion Explainer

It is a scientific fact that the embryo or fetus within the mother’s womb is a distinct human being, and, consequently, abortion ends the life of that human being.

Maternal & Public Health

Fact Sheet: Miscarriage Management with Mifepristone

If mifepristone is unavailable, patients will not suffer, for there are several other effective options available for treating a miscarriage. Fearmongering about an inability to treat miscarriages in the aftermath of Dobbs should be recognized for the ideologically driven, pro-abortion rhetoric that it is.

Maternal & Public Health

Wounded Women: The Consequences of “Choice”

It is a scientific fact that the embryo or fetus within the mother’s womb is a distinct human being, and, consequently, abortion ends the life of that human being.

featured-image
Maternal & Public Health

Fact Sheet: Opill, the First Over-the-Counter Hormonal Contraception

Opill, the first nonprescription oral contraceptive pill (OCP) to be granted FDA approval, is a synthetic progesterone (norgestrel) 0.075 mg tablet taken daily (with no placebo week). The following are important facts for women and physicians to know as Opill hits the market for the first time in 2024.

Life & the Law

Why We Need Federal Limits on Late Abortion to Protect Both Mother and Child

Most on the left vehemently oppose any legislative limits on abortion, and some on the right, even if they identify as pro-life, are of the opinion that a federal limit on late abortions would fail to find consensus and so could not be passed.

Maternal & Public Health

Twelve Reasons Women’s Health and Maternal Mortality Will Not Worsen, and May Improve, in States with Abortion Limits

Limiting abortion will not prohibit any life-saving medical interventions, as is clearly shown by every pro-life state law having exceptions for the life of the mother.

Maternal & Public Health

Fact Sheet: Out-of-State Abortion Complications

Abortion providers often abandon women who suffer complications from their procedures to be treated by other facilities.

featured-image
Maternal & Public Health

A Cohort Study of Mental Health Services Utilization Following a First Pregnancy Abortion or Birth

A first pregnancy abortion, compared to a birth, is associated with significantly higher subsequent mental health services utilization following the first pregnancy outcome. The risk attributable to abortion is notably higher for inpatient than outpatient mental health services.

Life & the Law

What is the Truth about the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration lawsuit?

In response to the AHM v. FDA lawsuit, The New York Times (NYT) published an article they said proves definitively that abortion pills are “safe and effective.” This paper will address the limitations of the NYT’s conclusions and provide a framework for a thorough examination of the entirety of the literature on this subject.

Maternal & Public Health

Induced Abortion with Misoprostol Alone

As abortion limits have been implemented in many states in the wake of the Supreme Court’s Dobbs decision, some perplexing recommendations have been advanced by abortion advocates and their media allies.